Plasminogen activator inhibitor-1 promoter 4G/5G genotype and plasma levels in relation to a history of myocardial infarction in patients characterized by coronary angiography.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Arteriosclerosis, Thrombosis and Vascular Biology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.ATV.17.1.33PMID 9012634
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Promoter (4G/5G) plasminogen activator inhibitor-1 genotype in Pima Indians: relationship to plasminogen activator inhibitor-1 levels and features of the insulin resistance syndrome

  1996cited by this paper
• Determinants of Plasminogen Activator Inhibitor 1 Activity in Treated NIDDM and Its Relation to a Polymorphism in the Plasminogen Activator Inhibitor 1 Gene

  1995cited by this paper
• The 4G/5G Genetic Polymorphism in the Promoter of the Plasminogen Activator Inhibitor-1 (PAI-1) Gene Is Associated with Differences in Plasma PAI-1 Activity but not with Risk of Myocardial Infarction in the ECTIM Study

  1995cited by this paper
• Plasminogen Activator Inhibitor-1 (PAI-1) Promoter Polymorphism and Coronary Artery Disease in Non-Insulin-Dependent Diabetes

  1995cited by this paper
• Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction.

  1995cited by this paper
• Environmental and Genetic Factors in Relation to Elevated Circulating Levels of Plasminogen Activator Inhibitor-1 in Caucasian Patients with Non-Insulin-Dependent Diabetes Mellitus

  1995cited by this paper
• Polymorphisms of the Plasminogen Activator Inhibitor- 1 Gene in Type 1 and Type 2 Diabetes, and in Patients with Diabetic Retinopathy

  1994cited by this paper
• ECAT angina pectoris study: baseline associations of haemostatic factors with extent of coronary arteriosclerosis and other coronary risk factors in 3000 patients with angina pectoris undergoing coronary angiography.

  1993cited by this paper
• The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells.

  1993cited by this paper
• Evidence of impaired endothelium-dependent coronary vasodilatation in patients with angina pectoris and normal coronary angiograms.

  1993cited by this paper
• The cardiovascular risk factor plasminogen activator inhibitor type 1 is related to insulin resistance.

  1993cited by this paper
• Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries.

  1992cited by this paper
• Increased plasma plasminogen activator inhibitor 1 levels. A possible link between insulin resistance and atherothrombosis

  1991cited by this paper
• The Acute Effect of Insulin on Tissue Plasminogen Activator and Plasminogen Activator Inhibitor in Man

  1991cited by this paper
• Elevated fibrinogen and plasminogen activator inhibitor (PAI‐1) in hypertension are related to metabolic risk factors for cardiovascular disease

  1990cited by this paper
• Increased Plasminogen Activator Inhibitor Activity in Non Insulin Dependent Diabetic Patients – Relationship with Plasma Insulin

  1989cited by this paper
• Plasminogen activator inhibitors--a review.

  1988cited by this paper
• Plasminogen activator inhibitors.

  1987cited by this paper
• Relationships between plasma insulin triglyceride, body mass index, and plasminogen activator inhibitor 1.

  1987cited by this paper
• Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction.

  1987cited by this paper
• Fibrinogen, fibrin and fibrin degradation products in relation to atherosclerosis.

  1986cited by this paper
• Seven year survival of patients with normal or near normal coronary arteriograms: a CASS registry study.

  1986cited by this paper
• Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction.

  1985cited by this paper
• Plasminogen activator inhibitor in the blood of patients with coronary artery disease.

  1985cited by this paper
• Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death.

  1984cited by this paper
• Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction.

  1980cited by this paper

• NF1 with Multiple Cardiac Structural Abnormalities Leading to Cerebral Infarction

  2026cites this paper
• Plasminogen activator inhibitor-1 gene promoter 4G/5G polymorphism and risks of peripherally inserted central catheter–related venous thrombosis in patients with lung cancer: a prospective cohort study

  2021cites this paper
• Plasminogen activator inhibitor-1 activity and the 4G/5G polymorphism are prospectively associated with blood pressure and hypertension status.

  2019cites this paper
• Plasminogen activator inhibitor-1 polymorphisms as a risk factor for chronic periodontitis in North Indian population.

  2019cites this paper
• Chapter 30 – Cardiovascular Genetics

  2018cites this paper
• Association of plasminogen activator inhibitor-1 gene 4G/5G polymorphism in ST elevation acute myocardial infarction in young patients less than 45 years

  2018cites this paper
• Genetics of myocardial infarction: The role of thrombosis-associated genes. A review article

  2017cites this paper
• The contribution of different adipose tissue depots to plasma plasminogen activator inhibitor-1 (PAI-1) levels.

  2016cites this paper
• The Association between PAI-1 Gene Promoter Polymorphism and Serum Serpin E1, MDA, and Hs-CRP Levels in Coronary Artery Disease

  2016cites this paper
• Plasminogen activator inhibitor-1 in black South Africans, methodological and clinical considerations

  2016cites this paper
• PAI-1 4 G / 5 G polymorphism and coronary artery disease risk : a meta-analysis

  2015cites this paper
• PREDISPOSANT FACTORS FOR INTIMAL HYPERPLASIA AND THEIR MECHANISMS OF ACTION IN OPEN VASCULAR SURGERY. A REVIEW.

  2015cites this paper
• PAI-1 4G/5G polymorphism and coronary artery disease risk: a meta-analysis.

  2015cites this paper
• The association between plasminogen activator inhibitor type 1 (PAI-1) levels, PAI-1 4G/5G polymorphism, and myocardial infarction: a Mendelian randomization meta-analysis

  2014cites this paper
• Plasminogen activator inhibitor-1 4G/5G polymorphism is associated with coronary artery disease risk: a meta-analysis.

  2014cites this paper
• The study of t-PA, u-PA and PAI-1 genes polymorphisms in patients with abdominal aortic aneurysm

  2014cites this paper
• Plasminogen Activator Inhibitor-1 (PAI-1) 4G/5G Allele Polymorphisms and NIDDM(Non-Insulin Dependent Diabetes Mellitus) Risk Factor for Early Onset Myocardial Infarction

  2014cites this paper
• Common Genetic Determinants of Coagulation and Fibrinolysis

  2013cites this paper
• In Black South Africans from Rural and Urban Communities, the 4G/5G PAI-1 Polymorphism Influences PAI-1 Activity, but Not Plasma Clot Lysis Time

  2013influential citation
• Thrombophilic Gene Mutations / Polymorphisms in Young Patients with Myocardial Infarction

  2013cites this paper
• oscillation of plasma PAI-1 The 4G5G polymorphism in the gene for PAI-1 and the circadian

  2013cites this paper
• Plasminogen activator inhibitor-1 5G/5G genotype is associated with early spontaneous recanalization of the infarct-related artery in patients presenting with acute ST-elevation myocardial infarction

  2013cites this paper
• Coagulation abnormalities in osteonecrosis and bone marrow edema syndrome.

  2013cites this paper
• PAI-1 4G/5G gene polymorphism is associated with angiographic patency in ST-elevation myocardial infarction patients treated with thrombolytic therapy

  2012cites this paper
• Influence of PAI-1 gene promoter-675 (4G/5G) polymorphism on fibrinolytic activity after cardiac surgery employing cardiopulmonary bypass.

  2012cites this paper
• Vessel wall integrity influence of genetics and flow

  2012cites this paper
• Association between the rs6950982 polymorphism near the SERPINE1 gene and blood pressure and lipid parameters in a high-cardiovascular-risk population: interaction with Mediterranean diet

  2012cites this paper
• Association of tissue plasminogen activator and plasminogen activator inhibitor polymorphism with myocardial infarction: a meta-analysis.

  2012cites this paper
• Plasminogen Activator Inhibitor 1 (Pai-1) as an Adipokine

  2011cites this paper
• 4G/5G polymorphism and haplotypes of SERPINE1 in atherosclerotic diseases of coronary arteries

  2010cites this paper
• Plasminogen Activator Inhibitor Type-1 Gene 4G/5G Polymorphism Is Associated with Hypertensive Patients in the Turkish Population

  2010cites this paper
• Role of Genetic Polymorphism of Angiotensin-Converting Enzyme, Plasminogen Activator Inhibitor-1 and Endothelial Nitric Oxide Synthase in the Prognosis of Coronary Artery Disease

  2010cites this paper
• Reduced carriership of 4G allele of plasminogen activator inhibitor-1 4G/5G polymorphism in very young survivors of myocardial infarction

  2010cites this paper
• Association of PAI-1 4G/5G and -844G/A Gene Polymorphisms and Changes in PAI-1/Tissue Plasminogen Activator Levels in Myocardial Infarction: A Case-Control Study

  2010cites this paper
• The Regulation of Human PAI-1 Levels in Blood

  2009cites this paper
• Heritability of Clot Formation

  2009cites this paper
• Plasminogen activator inhibitor-1 4G4G genotype is associated with myocardial infarction but not with stable coronary artery disease

  2008cites this paper
• Low HDL Cholesterol, Smoking and IL-13 R130Q Polymorphism are Associated with Myocardial Infarction in Greek Cypriot Males. A Pilot Study

  2008cites this paper
• Genetic determinants in ischemic heart disease.

  2008cites this paper
• Type 2 diabetes significantly modulates the cardiovascular risk conferred by the PAI-1 -675 4G/5G polymorphism in angiographied coronary patients.

  2008cites this paper
• Sequence variations within the genes related to hemostatic imbalance and their impact on coronary artery disease in Turkish population.

  2007cites this paper
• Gene polymorphisms of tissue plasminogen activator and plasminogen activator inhibitor-1 in Turkish patients with generalized aggressive periodontitis.

  2007cites this paper
• Tissue plasminogen activator and plasminogen activator inhibitor-1 gene polymorphisms in patients with chronic periodontitis.

  2007cites this paper
• Major and Potential Prothrombotic Genotypes in Patients with Venous Thrombosis and in Healthy Subjects from Slovenia

  2007cites this paper
• Plasminogen activator inhibitor type 1 gene polymorphisms and haplotypes are associated with plasma plasminogen activator inhibitor type 1 levels but not with myocardial infarction or stroke.

  2006cites this paper
• Molecular Pathogenesis of Cardiovascular Disease

  2006cites this paper
• Asociación del polimorfismo 4G/5G del gen PAI-1 con el perfil de lípidos en pacientes con artritis reumatoide, osteoartritis y controles clínicamente sanos

  2006cites this paper
• GENSKI POLIMORFIZMI IN AKUTNI KORONARNI SINDROM

  2006cites this paper
• Plasminogen Activator Inhibitor-1 Gene: Selection of Tagging Single Nucleotide Polymorphisms and Association With Coronary Heart Disease

  2006cites this paper
• [Associations of hemostasis factors genes with early development of ischemic heart disease and manifestation of myocardial infarction in young age].

  2005cites this paper
• The plasminogen activator inhibitor-1 (PAI-1) promoter haplotype is related to PAI-1 plasma concentrations in lean individuals.

  2005cites this paper
• Age‐related increase of pulse pressure and plasminogen activator inhibitor‐1 I/D gene polymorphism in essential hypertension

  2005cites this paper
• Candidate gene susceptibility variants predict intermediate end points but not angiographic coronary artery disease.

  2005cites this paper
• Aging and plasminogen activator inhibitor-1 (PAI-1) regulation: implication in the pathogenesis of thrombotic disorders in the elderly.

  2005cites this paper
• The fibrinolytic enzyme system : New markers of potential interest in cardiovascular disease

  2005cites this paper
• fhe4G/5G Polymorphism in the Plasminogen Activator Inhibitor-1 Gene Is not Associated with Myocardial Infarction

  2005cites this paper
• A novel polymorphism in the factor XIII B‐subunit (His95Arg): relationship to subunit dissociation and venous thrombosis

  2005cites this paper
• Relationship between postrenal transplant osteonecrosis of the femoral head and gene polymorphisms related to the coagulation and fibrinolytic systems in Japanese subjects

  2004cites this paper
• Plasminogen activator inhibitor-type 1: its plasma determinants and relation with cardiovascular risk

  2004cites this paper
• Association of plasminogen activator inhibitor-1 4G/5G gene polymorphism with variations in the LDL particle size in healthy Japanese men.

  2004cites this paper
• Effects of perindopril treatment on hemostatic function in patients with essential hypertension in relation to angiotensin converting enzyme (ACE) and plasminogen activator inhibitor-1 (PAI-1) gene polymorphisms.

  2004cites this paper
• Physiopathologie et étiopathogénie de l’infarctus du myocarde

  2004cites this paper
• Polymorphismes genetiques utilises comme diagnostics predictifs des effets indesirables de medicaments (adr) et de l'efficacite de ceux-ci

  2004cites this paper
• [Tissue plasminogen activator and plasminogen activator inhibitor gene polymorphisms: possible relation to atherosclerosis and its complications].

  2003cites this paper
• Promoter (4G/5G) Plasminogen Activator Inhibitor-1 Genotype and Plasminogen Activator Inhibitor-1 Levels in Blacks, Hispanics, and Non-Hispanic Whites: The Insulin Resistance Atherosclerosis Study

  2003cites this paper
• Relationships between fibrinogen, plasminogen activator inhibitor-1, and their gene polymorphisms in current smokers with essential hypertension.

  2003cites this paper
• 4G/5G PAI-1 Promoter Polymorphism and Acute-Phase Levels of PAI-1 Following Coronary Bypass Surgery: A Prospective Study

  2003cites this paper
• The genetics of atherothrombotic disorders: a clinician's view

  2003cites this paper
• 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene and risk of restenosis after coronary artery stenting.

  2003cites this paper
• The 4G5G polymorphism in the gene for PAI-1 and the circadian oscillation of plasma PAI-1.

  2003cites this paper
• 4G/5G promoter polymorphism of plasminogen activator inhibitor-1, lipid profiles, and ischemic stroke.

  2003cites this paper
• PAI-1 level and the PAI-1 4G/5G polymorphism in relation to risk of non-fatal myocardial infarction

  2003cites this paper
• The PAI-I gene 4G/5G Polymorphism and Deep Vein Thrombosis in Patients with Inherited Thrombophilia

  2003cites this paper
• Polymorphisms Related to Acute Coronary Syndromes and Heart Failure

  2003cites this paper
• Mecanismes trombòtics a la Sìndrome Antifosfolipídica i a les vasculitis

  2003cites this paper
• The plasminogen activator inhibitor‐1 −675 4G/5G genotype influences the risk of myocardial infarction associated with elevated plasma proinsulin and insulin concentrations in men from Europe: the HIFMECH Study

  2003cites this paper
• Plasminogen activator inhibitor-1 (PAI-1) activity post myocardial infarction: the role of acute phase reactants, insulin-like molecules and promoter (4G/5G) polymorphism in the PAI-1 gene.

  2003cites this paper
• Fibrinolysis, inflammation and cardiovascular disease; Epidemiological studies on Plasminogen activator inhibitor-type 1 and C-reactive protein

  2003cites this paper
• Antagonists of the angiotensin II type 1 receptor: an approach to control vascular disease beyond blood pressure lowering?

  2002cites this paper
• Interaction of hemostatic genetics with hormone therapy: new insights to explain arterial thrombosis in postmenopausal women.

  2002cites this paper
• Microangiopathic injury and augmented PAI-1 in human diabetic nephropathy.

  2002cites this paper
• Stress, inflammation and cardiovascular disease.

  2002cites this paper
• Association of beta-fibrinogen and factor VII polymorphism with plasma fibrinogen and factor VII levels, and no association of PAI-1 polymorphism with plasma PAI-1 levels in hemodialysis patients.

  2002cites this paper
• Obesity, haemostasis and the fibrinolytic system

  2002cites this paper
• Heritability of features of the insulin resistance syndrome in a community‐based study of healthy families

  2002cites this paper
• The Association of PAI-1 Promoter 4G/5G Insertion/Deletion Polymorphism with Myocardial Infarction and Stroke in Young Women

  2002cites this paper
• Genetic Contribution to Circulating Levels of Hemostatic Factors in Healthy Families With Effects of Known Genetic Polymorphisms on Heritability

  2002cites this paper
• The 4G/5G-polymorphism in the PAI-1 gene is not associated with markers of atherosclerosis in male smokers.

  2002cites this paper
• Hypofibrinolysis, Thrombophilia, Osteonecrosis

  2001cites this paper
• The plasminogen activator inhibitor (PAI)‐1 promoter 4G/4G genotype is not associated with ischemic stroke in a population of German children

  2001cites this paper
• Gene polymorphisms of the haemostatic system and the risk of arterial thrombotic disease

  2001cites this paper
• Plasminogen activator inhibitor type-1 in cardiovascular disease. Status report 2001.

  2001cites this paper
• The C766T low-density lipoprotein receptor related protein polymorphism and coronary artery disease, plasma lipoproteins, and longevity in the Czech population

  2001cites this paper
• Progression and potential regression of glomerulosclerosis.

  2001cites this paper
• 4G/5G Polymorphism of the Plasminogen Activator Inhibitor-1 Gene and Insertion/Deletion Polymorphism of the Tissue-Type Plasminogen Activator Gene in Atherothrombotic Stroke

  2001cites this paper
• Haemostatic Genetic Risk Factors in Arterial Thrombosis

  2001cites this paper
• Role of the 4G/5G Polymorphism of PAI-1 Gene Promoter on PAI-1 Levels in Obese Patients

  2001cites this paper
• [Gene polymorphisms of hemostasis and coronary risk].

  2001cites this paper
• Genetic Markers of Hemostatic Factors

  2001cites this paper
• Role of angiotensin II in glomerular injury.

  2001cites this paper